XML 92 R84.htm IDEA: XBRL DOCUMENT v3.23.4
Subsequent Events (Details)
12 Months Ended
Dec. 11, 2023
USD ($)
D
Dec. 31, 2022
USD ($)
Subsequent Events    
Payment of cash   $ (2,719,899)
Elusys Therapeutics    
Subsequent Events    
Liabilities and manufacturing commitments $ 40,000,000  
Payment of cash $ 500,000  
Percentage of royalty fee 3.00%  
Royalty fees $ 5,000,000  
Outstanding royalty expenses $ 5,000,000  
Debt instrument interest rate 1.00%  
Debt instrument weighted average interest rate 110.00%  
Debt instrument conversion of value issued upon conversion $ 2,250,000  
Debt instrument trading days | D 7